Who is the largest CBD company?

The largest company with a CBD product based on market cap is Jazz Pharmaceuticals.

Is CBD a good business to invest in?

The CBD industry could be a good investment choice if the regulations included in the 2018 Farm Bill are reinstated or if the FDA changes its policies to allow CBD in food supplements. For now, though, the industry's growth prospects could be somewhat limited.

What state buys the most CBD?

California is the biggest CBD market in the U.S.

How do regulations affect CBD stocks?

Federal and state regulations have significant impacts on CBD stocks, including:Laws and regulations regarding the THC (tetrahydrocannabinol) level allowed in the cannabis used in CBD products can change and vary from state to state.Individual states can limit access to their markets for CBD products.The quality and testing standards for CBD can vary from state to state, driving higher costs for CBD companies.Future FDA regulations on CBD in food, beverages, and dietary products could greatly affect the growth potential of CBD stocks.

How are CBD stocks different from regular cannabis stocks?

Cannabis stocks are shares of publicly traded companies that grow, process, or market cannabis products or provide products and services to other companies in the cannabis industry. CBD stocks are shares of publicly traded companies that are involved in the processing and distribution of CBD or provide tools and services to other companies in the CBD industry. The main differences between cannabis and CBD stocks are the legal and regulatory restrictions that they face and their market access. Cannabis stocks are more heavily regulated than CBD stocks.

Should I invest in individual CBD companies or ETFs?

The answer to this question depends on your risk tolerance. Investing in individual CBD companies offers the potential for higher rewards, but it also involves greater risk than investing in an ETF that owns a basket of stocks.

Is CBD a growing industry?

Yes, the CBD market is projected to grow from around $20.3 billion in 2026 to $62.6 billion by 2030.

4 Best CBD Stocks for 2026 and How to Invest

Here's what you need to know about the top CBD stocks.

By Keith Speights – Updated Jul 13, 2026 at 10:20 AM EST | Fact-checked by Margo Winton Parodi

Key Points

After 2018 federal legalization, U.S. CBD market growth didn't meet investor expectations.
Recent regulatory changes by U.S. Congress may further impact the CBD industry in 2026.
Investors should consider these changes and company fundamentals when selecting CBD stocks.

CBD stocks are shares of publicly traded companies that are involved in the processing and distribution of CBD or that provide tools and services to other companies in the CBD industry. CBD, or cannabidiol, is a chemical found in the cannabis plant. Sometimes, the best time to invest in a relatively new market is after the initial euphoria has evaporated. Could that be the case with investing in CBD stocks? Maybe.

The U.S. legalized hemp-derived CBD at the federal level with the 2018 Farm Bill. The mere anticipation of this legislation's passage stoked investor interest in companies in the CBD industry.

Although federal legalization served as a key milestone, the U.S. Food and Drug Administration (FDA) chose to exclude CBD from food supplements. As a result, the CBD opportunity in the U.S. hasn't lived up to investors' lofty ambitions.

The CBD industry faces another big challenge in 2026. A continuing resolution passed by the U.S. Congress in November 2025 made significant changes to federal hemp product regulations.

4 top CDB stocks for 2026

Although the CBD market isn't as attractive as it once was due to the uncertainties created by these changes, investors may still want to consider the following four CBD stocks.

Loading paragraph...

Ticker Information Table
Name and ticker	Current price	Market capMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Cresco Labs (OTC:CRLBF)	$0.77	$290.5 million
Green Thumb Industries (OTC:GTBIF)	$7.26	$1.6 billion
Jazz Pharmaceuticals Plc (NASDAQ:JAZZ)	$239.32	$15.0 billion
Trulieve Cannabis (NYSE:TRLV)	$8.63	$1.7 billion

Data as of Jul 15, 2026. Showing 4 of 4 total entries.

Loading ticker_table...

1. Cresco Labs

OTC: CRLBF

Cresco Labs

Today's Change

(-1.65%) $-0.01

Current Price

$0.77

Key Data Points

Market Cap

$291M

Day's Range

$0.75 - $0.79

52wk Range

$0.50 - $2.30

Volume

334.1K

Avg Vol

760.7K

Gross Margin

46.13%

Loading company_card...

Cresco Labs (CRLBF -1.65%) is an Illinois-based cannabis operator that markets recreational and medical cannabis products in eight states. The company is more than just a cannabis producer and retailer. Cresco also markets branded cannabis products containing CBD, including its Wonder gummies. It commands the leading market share in multiple markets of $1 billion or more.

Cresco has grown significantly through the years, both organically and through acquisitions, and it consistently generates solid free cash flow. The company also stands to benefit from tax changes related to the federal rescheduling of marijuana.

Perhaps the biggest knock against Cresco is that the company can't list its shares on a major U.S. stock exchange as long as marijuana remains illegal at the federal level. However, Cresco has proven that it can still attract investors through the U.S. over-the-counter (OTC) markets.

2. Green Thumb Industries

Loading paragraph...

OTC: GTBIF

Green Thumb Industries

Today's Change

(-3.46%) $-0.26

Current Price

$7.26

Key Data Points

Market Cap

$1.6B

Day's Range

$7.26 - $7.56

52wk Range

$5.29 - $10.43

Volume

808.7K

Avg Vol

592.2K

Gross Margin

45.02%

Loading company_card...

Like Cresco Labs, Green Thumb Industries (GTBIF -3.46%) is a U.S. cannabis operator based in Illinois. The company has dispensaries in 14 states as of mid-2026. Green Thumb markets multiple brands in its Rise dispensaries, including Rythm, which offers a lineup of CBD products.

The company is profitable and generates positive cash flow. It continued to grow, expanding into Minnesota in 2025 and adding 12 new locations throughout the U.S., bringing its total to 113.

3. Jazz Pharmaceuticals

Loading paragraph...

NASDAQ: JAZZ

Jazz Pharmaceuticals Plc

Today's Change

(0.53%) $1.27

Current Price

$239.32

Key Data Points

Market Cap

$15B

Day's Range

$233.46 - $240.93

52wk Range

$105.00 - $250.49

Volume

610.3K

Avg Vol

928.6K

Gross Margin

72.85%

Loading company_card...

You might be surprised to find a pharmaceutical stock listed among the top CBD stocks to consider. But Jazz Pharmaceuticals (JAZZ +0.53%) has a direct and important connection to CBD. In 2018, the company's Epidiolex became the first CBD product made from the cannabis plant to win FDA approval.

Jazz actually didn't own Epidiolex at that time. It acquired GW Pharmaceuticals, which developed the CBD drug to treat epileptic seizures, for $6.7 billion in 2021. Epidiolex generated annual sales of $1.1 billion in 2025. Sales continue to pick up, as the drug is now approved in more than 35 countries outside the U.S.

Jazz also has other growth drivers in its lineup. Sleep disorder drug Xywav is gaining momentum. The company also launched its biliary tract cancer drug Ziihera in December 2024, and its newest product, Modeyso, used to treat diffuse midline glioma, was granted FDA approval in August 2025.

4. Trulieve Cannabis

Loading paragraph...

NYSE: TRLV

Trulieve Cannabis

Today's Change

(-4.75%) $-0.43

Current Price

$8.63

Key Data Points

Market Cap

$1.7B

Day's Range

$8.53 - $9.27

52wk Range

$4.00 - $13.28

Volume

701.9K

Avg Vol

1.1M

Gross Margin

49.56%

Loading company_card...

Trulieve Cannabis (OTC:TCNNF) is a Florida-based cannabis operator. It has retail dispensaries in eight states and cultivation and processing facilities in seven states. The company is especially dominant in its home state's medical cannabis market. Roughly two-thirds of Trulieve's retail locations are in Florida. Trulieve also has leading market positions in Arizona and Pennsylvania.

Like Cresco Labs and Green Thumb Industries, Trulieve generates most of its revenue from cannabis sales. However, it also markets CBD products, including tinctures.

Trulieve experienced a setback when Florida voters rejected a constitutional amendment in November 2024 that would have legalized recreational marijuana. The amendment required 60% approval to pass, but it received only around 56%.

However, supporters plan to continue pushing for the legalization of recreational marijuana. Trulieve could still have a major growth opportunity in its home state in the future.

How to invest in CBD stocks

Follow these steps to invest in CBD stocks:

Open your brokerage account: Log in to your brokerage account where you handle your investments. If you don't have one yet, take a look at our favorite brokers and trading platforms to find the right one for you.
Search for the stock: Enter the ticker into the search bar to bring up the stock's trading page.
Decide how many shares to buy: Consider your investment goals and how much of your portfolio you want to allocate to this stock.
Select order type: Choose between a market order to buy at the current price or a limit order to specify the maximum price you're willing to pay.
Submit your order: Confirm the details and submit your buy order.
Review your purchase: Check your portfolio to ensure your order was filled as expected and adjust your investment strategy accordingly.

Loading paragraph...

Benefits and risks of investing in CBD stocks

The benefits of investing in CBD stocks include:

Potential to profit from promising markets such as personalized CBD and pet CBD products
Regulatory changes, including the rescheduling of marijuana, could help CBD stocks
Low valuations for many CBD stocks could lead to outsize gains in the future

However, there are also several risks associated with investing in CBD stocks, including:

The potential for adverse regulatory changes
High volatility
Limited access to banking services
Intense competition

Methodology: How these stocks were chosen

The primary criterion for selecting these four stocks was that they be actively involved in the CBD industry. However, CBD products didn't have to be the companies' main source of revenue.

Another factor was market cap. Only companies with market caps of at least $200 million were considered.

Market leadership and growth prospects were also important factors in the selection process. Each of the four stocks ranks among the leaders in its respective market and should have good long-term growth potential.

Should you invest in CBD stocks?

Risk-averse investors will probably be better off avoiding CBD stocks, as these stocks can be highly volatile. It's also best to consider buying CBD stocks only if you have a long-term investing horizon.

CBD stocks could be especially attractive to investors whose portfolios are heavily weighted with stable, defensive holdings.

Loading paragraph...

FAQ

Investing in CBD stocks FAQ

Loading faq...

About the Author

Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.

TMFFishBiz

Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends Cresco Labs and Green Thumb Industries. The Motley Fool has a disclosure policy.

4 Best CBD Stocks for 2026 and How to Invest

Here's what you need to know about the top CBD stocks.

Key Points

4 top CDB stocks for 2026

1. Cresco Labs

Key Data Points

2. Green Thumb Industries

Key Data Points

3. Jazz Pharmaceuticals

Key Data Points

4. Trulieve Cannabis

Key Data Points

How to invest in CBD stocks

Benefits and risks of investing in CBD stocks

Methodology: How these stocks were chosen

Should you invest in CBD stocks?

Related investing topics

Biotech vs. Pharma: What's the Difference?

5 Best Psychedelic Stocks for 2026 and How to Invest

5 Best Biotech Stocks for 2026 and How to Invest

6 Best Healthcare Stocks for 2026 and How to Invest

FAQ

Investing in CBD stocks FAQ

Who is the largest CBD company?

Who is the largest CBD company?

Is CBD a good business to invest in?

Is CBD a good business to invest in?

What state buys the most CBD?

What state buys the most CBD?

How do regulations affect CBD stocks?

How do regulations affect CBD stocks?

How are CBD stocks different from regular cannabis stocks?

How are CBD stocks different from regular cannabis stocks?

Should I invest in individual CBD companies or ETFs?

Should I invest in individual CBD companies or ETFs?

Is CBD a growing industry?

Is CBD a growing industry?

About the Author

Read Next

Stocks Mentioned

Motley Fool Stock Advisor’s Latest Pick

Premium Investing Services

4 top CDB stocks for 2026

2. Green Thumb Industries

Key Data Points

3. Jazz Pharmaceuticals

Key Data Points

4. Trulieve Cannabis

Key Data Points

How to invest in CBD stocks

Benefits and risks of investing in CBD stocks

Methodology: How these stocks were chosen

Should you invest in CBD stocks?

Biotech vs. Pharma: What's the Difference?

5 Best Psychedelic Stocks for 2026 and How to Invest

5 Best Biotech Stocks for 2026 and How to Invest

6 Best Healthcare Stocks for 2026 and How to Invest

Investing in CBD stocks FAQ

Who is the largest CBD company?

Who is the largest CBD company?

Is CBD a good business to invest in?

Is CBD a good business to invest in?

What state buys the most CBD?

What state buys the most CBD?

How do regulations affect CBD stocks?

How do regulations affect CBD stocks?

How are CBD stocks different from regular cannabis stocks?

How are CBD stocks different from regular cannabis stocks?

Should I invest in individual CBD companies or ETFs?

Should I invest in individual CBD companies or ETFs?

Is CBD a growing industry?

Is CBD a growing industry?

Key Data Points